BIOLASE (NASDAQ:BIOL) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of BIOLASE (NASDAQ:BIOL) in a research note published on Friday. The firm issued a sell rating on the medical technology company’s stock.

A number of other equities research analysts have also recently issued reports on BIOL. Maxim Group cut shares of BIOLASE from a strong-buy rating to a hold rating in a research report on Friday, May 24th. Benchmark restated a speculative buy rating and set a $0.40 target price on shares of BIOLASE in a report on Monday, August 12th.

BIOLASE Price Performance

BIOL opened at $0.05 on Friday. The company has a market capitalization of $1.57 million, a P/E ratio of 0.00 and a beta of 0.71. The firm’s fifty day moving average price is $0.09 and its two-hundred day moving average price is $0.17. BIOLASE has a fifty-two week low of $0.04 and a fifty-two week high of $6.00.

BIOLASE (NASDAQ:BIOL) last issued its earnings results on Thursday, August 8th. The medical technology company reported ($0.08) earnings per share for the quarter. BIOLASE had a negative net margin of 43.56% and a negative return on equity of 1,782.73%. The business had revenue of $11.56 million for the quarter.

Institutional Investors Weigh In On BIOLASE

An institutional investor recently raised its position in BIOLASE stock. Virtu Financial LLC raised its holdings in shares of BIOLASE, Inc. (NASDAQ:BIOL) by 1,068.0% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 143,537 shares of the medical technology company’s stock after purchasing an additional 131,248 shares during the period. Virtu Financial LLC owned 0.43% of BIOLASE worth $27,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 8.79% of the company’s stock.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.